<DOC>
	<DOCNO>NCT02459990</DOCNO>
	<brief_summary>Assess Fetal Mortality Malformations Women treat antihypertensive medication preganancy . Mother - Child pair analyse cohort select UK CPRD database . Years cover 1997 2014 . Aim ass risk Antihypertensive treatment woman .</brief_summary>
	<brief_title>Congenital Malformations Maternal Use Anti-hypertensive Medication United Kingdom</brief_title>
	<detailed_description>Women chronic hypertension risk experience severe complication adverse effect fetal growth , survival , renal function pregnancy . General recommendation advocate treatment high blood pressure pregnancy decrease risk mother child , extreme caution . Many study assess risk congenital malformation infant whose mother treat anti-hypertensive medication inconclusive , part due variability original data source possibly robustness analyses.2 Studies regard health issue unable stratify anti-hypertensive medication sufficiently truly assess risk per drug class , Angiotensin II Receptor Antagonists/Blockers ( ARBs ) Angiotensin-converting-enzyme inhibitor ( ACE inhibitor ) particular.We attempt assess prescription rate ARBs ACE inhibitor among woman high blood pressure United Kingdom ( UK ) estimate risk serious foetal outcome woman treat ARBs and/or ACEs may also follow co-morbid condition : Diabetes Types I II , Diabetic Nephropathy , Congestive Heart Failure .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>age gender</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Hypertension malformation fetal mortality</keyword>
</DOC>